Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team (Q40689581)
Jump to navigation
Jump to search
scientific article published on February 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team |
scientific article published on February 1995 |
Statements
1 reference
Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team (English)
1 reference
Fischl M
1 reference
Reichman RC
1 reference
Morse GD
1 reference
Demeter LM
1 reference
Resnick L
1 reference
Bassiakos Y
1 reference
Para M
1 reference
Powderly W
1 reference
Leedom J
1 reference
Greisberger C
1 reference
1 February 1995
1 reference
1 reference
171
1 reference
2
1 reference
297-304
1 reference
Identifiers
1 reference
1 reference